Navigation Links
Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
Date:4/27/2012

GREENWOOD VILLAGE, Colo., April 27, 2012 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE), a biopharmaceutical company conducting clinical trials on its three lead drugs (Ampion™, Optina™ and Zertane™), licensing distribution of these drugs and developing additional new drugs, today announced that it received notice of allowance of a patent from the US office of patents and trademarks for its DME drug Optina™. Ampio also received a notice of allowance of a similar patent from the Canadian Intellectual Property Office. These initial patents cover the North American territories and multiple additional patents for using Optina™ for the treatment of macular edema and diabetic retinopathy are pending worldwide.

According to Michael Macaluso, Ampio's CEO, "Optina™ is an ultra-low oral (capsule), not commercially available, dose of danazol for the treatment of DME. To our knowledge, no other oral drug to treat this condition exists and there is currently no drug approved by the FDA for this condition. The allowance of these patents in North America is an important step in the development and commercialization of this novel drug as they include multiple claims for the beneficial effects of ultra-low dose Optina™ on vascular hyperpermeability encountered in DME and other vascular leakage syndromes. These patents have an unusually long patent life that expires in 2030. In contrast, most drugs at this stage of development (just before a pivotal trial) have exhausted a large portion of their patent life. These patent claims provide especially strong protection because of the unexpected finding of efficacy only at the very low doses. Ampio is currently in discussions with potential partners to co-develop Optina™ for DME."

Dr. David Bar-Or, Chief Scientific Officer for Ampio, explained, "The mode of action of Optin
'/>"/>

SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Ampio Strengthens Patent Protection for Lead Drug Ampion™
2. Ampio Announces Positive Preliminary Update on the Optina™ Clinical Trial to Treat Diabetic Macular Edema and Decision to Conclude the Study Ahead of Schedule
3. Champions Oncology Reports Fiscal 2012 Third Quarter Financial Results
4. Ampio Pharmaceuticals Reports Full-Year 2011 Financial Results and Milestone Highlights for 2011
5. Ampio Pharmaceuticals Schedules 2012 Outlook Webcast
6. Executive Changes at Ampio
7. Ampio Pharmaceuticals Schedules Webcast to Update Shareholders
8. Ampio Pharmaceuticals Announces Registered Direct Common Stock Offering of Approximately $9.436 Million
9. Ampio Responds to Recent Publications by Anonymous Short Sellers
10. Champions Oncology Reports Fiscal 2012 Second Quarter Financial Results
11. FDA Advisory Panel Recommends Against Approval of Champion® Heart Failure Management System for Patients With Heart Failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... 31, 2015 The Wolf Administration today announced ... Pennsylvania State Police and local police ... Heroin and opioid overdose are the leading ... , killing more individuals than those involved in fatal ... from a drug overdose. " ...
(Date:8/31/2015)... HARRISBURG, Pa. , Aug. 31, 2015  The ... held an event today at Gaudenzia Concept 90 to ... the drug overdose crisis in Pennsylvania ... get treatment and focus on recovery through the ... too many Pennsylvanians are dying every day to a ...
(Date:8/31/2015)... , Aug. 31, 2015  Dipexium Pharmaceuticals, Inc. ... on the development and commercialization of Locilex® (pexiganan cream ... announced plans to participate in four investor conferences in ... 2015 at the Sidoti & Company, LLC Emerging Growth ... . David P. Luci , President & Chief ...
Breaking Medicine Technology:Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 2Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 3Pennsylvania Departments of Drug & Alcohol Programs and Health Kick-off Second Annual Building Bridges to Recovery Initiative 2Dipexium Pharmaceuticals Announces Participation in Four Investor Conferences in September 2Dipexium Pharmaceuticals Announces Participation in Four Investor Conferences in September 3
... SCOTTSDALE, Ariz. and WASHINGTON, June 15, 2011 The ... and CAQH CORE ® (Committee on Operating Rules ... collaborate on activities related to harmonizing electronic data interchange ... NCPDP and CAQH CORE began exploring the ...
... Endologix, Inc. (Nasdaq: ELGX ), developer and ... today that it has received U.S. Food and Drug ... AFX™ Endovascular AAA System, for the treatment of abdominal ... Annual Meeting of the Society for Vascular Surgery (SVS), ...
Cached Medicine Technology:NCPDP and CAQH CORE Partner on Harmonizing Operating Rules and Standards Across Healthcare 2NCPDP and CAQH CORE Partner on Harmonizing Operating Rules and Standards Across Healthcare 3Endologix Announces FDA Approval of AFX™ Endovascular AAA System 2Endologix Announces FDA Approval of AFX™ Endovascular AAA System 3
(Date:8/31/2015)... , ... August 31, 2015 , ... ... selected ezDI’s computer-assisted coding (CAC) software for its Clinical Documentation Improvement (CDI) and ... and a patent pending ICD-10 solution - ezCAC is an enterprise-level coding solution ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... may be at a greater risk for injury, potentially because they are more ... of Pittsburgh Graduate School of Public Health analysis discovered. , The research, ...
(Date:8/31/2015)... ... August 31, 2015 , ... Kognito ... and assess their competencies in managing challenging conversations, announced today that Glenn Albright, ... Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury (DCoE) Summit ...
(Date:8/31/2015)... IL (PRWEB) , ... August 31, 2015 , ... On ... With A Mission” at the Adams County Fairgrounds in Mendon, IL. The purpose behind ... school districts of Mendon and neighboring town, Quincy. Best Drug Rehabilitation’s sponsorship of “Music ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... future-proof its content management system (CMS) and make website updates quicker and more ... making the websites of the Bundesliga (the German equivalent of the U.S. Soccer ...
Breaking Medicine News(10 mins):Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 2Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 3Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 4Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 2Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 3Health News:Kognito’s Glenn Albright to Present at DCoE Summit 2Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 2Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 3Health News:On the Ball with FirstSpirit: German Soccer League (DFL Digital Sports) Opts for e-Spirit’s CMS 2
... for months or even// years have a high possibility of ... researchers of Montefiore Cough Center, US, have reported that of ... of nine years, 53% of them were also suffering from ... Society International Conference 2005. ,The researchers did a three ...
... a hereditary condition.// ,Researchers from Bonn University Clinic and ... for this condition. ,Scientists have narrowed down this genetic variance ... this gene had been found more often in men who lose ... who still sport a head full of hair at sixty. ...
... diet during pregnancy and lactation may be creating a ... ,Scientists from Louisiana State University who presented the ... American Association for Cancer Research said that babies who ... 3 fatty acids will be benefited the most from ...
... have been able to clone human embryos for creating stem ... or injury. The newly created stem cell lines are an ... ,This research have provided new insight into using stem ... as a treatemnt. This is for the first time human ...
... Scientists have developed a new blood test called Cystatin-C ... kidney malfunction. Earlier test that was used was creatinine, ... more effective and better predictor than the earlier one. ... risks: low, medium and high. The new test revealed ...
... from exercise may be a successful predictor for risk ... the changes in heart rate during exercise and recovery ... to find out whether heart rate can predict sudden ... more likely to occur if the healthy people tend ...
Cached Medicine News:
... test combines performance equivalence to 14-day viral culture ... B with a simple, easy-to-use test with results ... all the same procedural steps as our FLU ... decrease costs for unnecessary ancillary testing, improve appropriate ...
... The Acceava Mononucleosis test provides ... Mononucleosis with a simple procedure that ... Side-by-side evaluations with competitive products will ... These attributes enable you to deliver ...
Shielding's Flex Back Apron is one of our most popular. Similar to the Velcro Adjustable but with elastic back panels for additional support and comfort....
Shielding's Standard Coat Apron with open back allows for freedom of movement, maximum flexibility and increased comfort....
Medicine Products: